G01N 2333/9129
Transferases for other substituted phosphate groups
Official title: Transferases for other substituted phosphate groups (2.7.8)
G01N2333/9129 (Transferases for other substituted phosphate groups) appears on 23 US grants and 33 published applications in this corpus.
Search patents in G01N- Granted patents
- 23
- Published applications
- 33
- Assignees
- 14
- Inventors
- 26
- Latest grant
- 13 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 3 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 4 |
| 2014 | 2 | 1 |
| 2015 | 2 | 4 |
| 2016 | 2 | 8 |
| 2017 | 2 | 2 |
| 2018 | 1 | 3 |
| 2019 | 0 | 1 |
| 2020 | 5 | 0 |
| 2021 | 6 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Modular point-of-care devices, systems, and uses thereof13 Feb 2024US 11,899,010 B2Labrador Diagnostics LLC
- Modular point-of-care devices, systems, and uses thereof21 Jun 2022US 11,366,106 B2Labrador Diagnostics LLC
- Modular point-of-care devices, systems, and uses thereof14 Dec 2021US 11,199,538 B2Labrador Diagnostics LLC
- Modular point-of-care devices, systems, and uses thereof12 Oct 2021US 11,143,647 B2Labrador Diagnostics LLC
- Modular point-of-care devices, systems, and uses thereof5 Oct 2021US 11,137,391 B2Labrador Diagnostics LLC
- Modular point-of-care devices, systems, and uses thereof8 Sep 2022US 2022/0283150 A1Labrador Diagnostics LLC
- Modular point-of-care devices, systems, and uses thereof27 May 2021US 2021/0156848 A1
- Method for predicting responsiveness to phosphatidylserine synthase 1 inhibitor4 Jul 2019US 2019/0203304 A1Daiichi Sankyo Company, Limited
- Modular point-of-care devices, systems, and uses thereof23 Aug 2018US 2018/0238864 A1Theranos IP Company, LLC
- Modular point-of-care devices, systems, and uses thereof16 Aug 2018US 2018/0231536 A1Theranos IP Company, LLC
Most cited
By later US patents
- Modular point-of-care devices, systems, and uses thereof100US 8,088,593 B2Theranos, Inc. · 2012
- Modular point-of-care devices, systems, and uses thereof27US 9,435,793 B2Theranos, Inc. · 2016
- Modular point-of-care devices, systems, and uses thereof20US 8,822,167 B2Theranos, Inc. · 2014
- Modular point-of-care devices, systems, and uses thereof18US 9,012,163 B2Theranos, Inc. · 2015
- Modular point-of-care devices, systems, and uses thereof18US 9,121,851 B2Theranos, Inc. · 2015